Diamedica Therapeutics To Participate In 11th Annual Craig-hallum Alpha Select Conference

by finance.yahoo.com posted 7months ago 60 views
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical stage biopharmaceutical company developing novel treatments for chronic kidney diseases and neurological disorders, today announced its President and CEO, Rick Pauls, and Chief Financial Officer, Scott Kellen, are scheduled to participate in the Craig-Hallum Alpha Select Conference, which is being held as a virtual event on November 17, 2020.

In this article